Professional Documents
Culture Documents
Breast 1
Breast 1
Breast 1
treatment
Post operative
PREDICT/Nottingham
Prognostic Index
Will adjuvant
therapy potentially
help
ER+ HER2+
Oncotype DX
suggests chemotherapy useful.
Tumour >0.5cm
Trastuzumab &
Pertuzumab
Yes No with concurrent
Chemotherapy
(2-4 months)
Adjuvant No Adjuvant
Chemotherapy Chemotherapy
12 m total
Trastuzumab
Exemestane &
<35 >40 Tamoxifen
Ovarian Suppression
Aromatase inhibitors
High risk features Low risk featurea (Letrozole/ Anastrozole)
10 years 5 years